Mangement of Diabetic Retinopathy and Other Important Retinal Diseases at Bhandari Starlife eye hospital in Ludhiana

The retina is a thin, light-sensitive layer of tissue lining the back of the eye. It converts light into electrical signals that are transmitted to the brain through the optic nerve, enabling vision. The macula, located at the centre of the retina, is responsible for detailed central vision required for reading, recognising faces and performing fine visual tasks. Retinal diseases can affect central or peripheral vision and, if untreated, may lead to permanent visual impairment or blindness. Many retinal disorders are painless, and significant damage can occur before the patient notices symptoms. Early diagnosis through a comprehensive dilated fundus examination, retinal photography and optical coherence tomography (OCT) is therefore essential.

Common retinal diseases include diabetic retinopathy, age-related macular degeneration, retinal vascular occlusions, retinal detachment, central serous chorioretinopathy, epiretinal membrane, macular holes, inherited retinal dystrophies and retinopathy of prematurity. Their management ranges from systemic risk-factor control and observation to intravitreal injections, laser treatment and vitreoretinal surgery.

1. Diabetic Retinopathy treatment in Bhandari stralife eye hospital in Ludhiana

Diabetic retinopathy (DR) is a microvascular complication of diabetes mellitus caused by chronic hyperglycaemia and associated metabolic and vascular changes that damage the retinal capillaries. It is a major cause of preventable visual impairment among working-age adults. Prolonged diabetes, poor glycaemic control, hypertension, dyslipidaemia, kidney disease and pregnancy in women with diabetes can increase the risk of onset or progression. Diabetic retinopathy may remain asymptomatic in its early stages, making regular retinal screening essential even when visual acuity is normal.

Classification

Diabetic retinopathy is broadly classified into two main categories:

A. Non-proliferative diabetic retinopathy (NPDR): This is characterised by microaneurysms, retinal haemorrhages, hard exudates, cotton-wool spots and, in more advanced cases, venous beading and intraretinal microvascular abnormalities. NPDR is classified as mild, moderate or severe according to the extent of retinal lesions. Severe NPDR carries a greater risk of progression to proliferative disease.

B. Proliferative diabetic retinopathy (PDR): In advanced disease, retinal ischaemia stimulates the formation of abnormal new blood vessels on the retina or optic disc. These fragile vessels may bleed into the vitreous, cause preretinal haemorrhage and develop fibrovascular tissue, potentially resulting in tractional retinal detachment and severe visual loss. Neovascularisation of the iris and angle may also cause neovascular glaucoma.

Diabetic macular oedema (DME) may occur at any stage of diabetic retinopathy. Leakage from damaged retinal vessels causes fluid accumulation in the macula, leading to blurred central vision. OCT is particularly useful for detecting and monitoring macular oedema.

Diagnosis

Diagnosis is based on a dilated fundus examination, colour fundus photography and, where indicated, OCT, fluorescein angiography or OCT angiography. Fundus photography is useful for screening and documenting progression. OCT provides cross-sectional images of the macula and helps quantify oedema. Fluorescein angiography may identify areas of leakage, capillary non-perfusion and neovascularisation when further evaluation is required.

Management

Effective management involves optimising blood glucose, blood pressure and lipid levels, together with regular retinal monitoring. Patients with diabetes should receive retinal screening at intervals appropriate to their disease status and local guidelines. Intravitreal anti-VEGF agents are commonly used for centre-involving DME with visual impairment and for selected cases of proliferative retinopathy. Intravitreal corticosteroids may be considered in selected patients with persistent macular oedema. Panretinal photocoagulation (PRP) remains an important treatment for PDR, particularly when reliable follow-up may be difficult. Vitrectomy may be required for non-clearing vitreous haemorrhage, tractional retinal detachment involving or threatening the macula, or selected cases of persistent complications. Early detection and appropriate treatment can substantially reduce the risk of severe visual loss.

2. Age-Related Macular Degeneration (AMD)

Age-related macular degeneration is a progressive disease affecting the macula, primarily in older adults. It impairs central vision while peripheral vision is often preserved. Risk factors include advancing age, smoking, family history, cardiovascular risk factors and genetic susceptibility.

AMD is classified into two main forms:

• Dry (non-neovascular) AMD: Characterised by drusen, pigmentary changes and, in advanced cases, geographic atrophy of the retinal pigment epithelium and photoreceptors.

• Wet (neovascular) AMD: Characterised by abnormal blood vessel growth beneath or within the retina, leading to fluid leakage, haemorrhage, scarring and rapid central visual loss.

Symptoms: Blurred central vision, distortion of straight lines (metamorphopsia), difficulty reading and a central dark or blank area in advanced disease.

Diagnosis: Dilated fundus examination, OCT, fundus photography and, when required, fluorescein angiography or OCT angiography.

Management: Early dry AMD requires risk-factor modification, smoking cessation and monitoring. AREDS2-type nutritional supplements may benefit appropriately selected patients with intermediate AMD or advanced AMD in one eye; they are not indicated for everyone. Wet AMD is primarily treated with intravitreal anti-VEGF injections, which can reduce leakage and preserve or improve vision. Selected cases of geographic atrophy may be eligible for newer treatments where available. Early recognition of new distortion or central visual changes is important.

3. Retinal Detachment

Retinal detachment occurs when the neurosensory retina separates from the underlying retinal pigment epithelium. The most common form is rhegmatogenous retinal detachment, caused by a retinal tear through which fluid enters the subretinal space. Risk factors include high myopia, previous cataract surgery, ocular trauma, lattice degeneration and a history of retinal detachment in the fellow eye.

Symptoms: Sudden onset of floaters, flashes of light, a curtain-like shadow or loss of peripheral vision. Central vision may be affected if the macula detaches.

Diagnosis: Urgent dilated peripheral retinal examination, often with indirect ophthalmoscopy and scleral indentation. B-scan ultrasonography is useful when the retina cannot be visualised adequately.

Management: A symptomatic retinal tear without established detachment may be treated with laser photocoagulation or cryotherapy. Retinal detachment generally requires urgent vitreoretinal assessment and surgery, such as pneumatic retinopexy, scleral buckling or pars plana vitrectomy, depending on the case. Visual prognosis is generally better when the macula remains attached.

Retinal detachment is an ophthalmic emergency. Patients with sudden flashes, numerous new floaters or a curtain-like shadow should seek immediate eye care.

4. Retinal Vein Occlusion

Retinal vein occlusion (RVO) is a retinal vascular disorder caused by obstruction of venous blood flow. It is classified as central retinal vein occlusion (CRVO) or branch retinal vein occlusion (BRVO). Hypertension, diabetes, dyslipidaemia, glaucoma and increasing age are important risk factors.

Clinical features: Sudden painless blurring or loss of vision in one eye. Fundus examination may reveal retinal haemorrhages, dilated tortuous veins, cotton-wool spots and macular oedema. Ischaemic CRVO may be associated with extensive retinal non-perfusion and subsequent neovascular complications.

Diagnosis: Dilated fundus examination, OCT to assess macular oedema, and fluorescein angiography or OCT angiography when assessment of retinal perfusion is required.

Management: Intravitreal anti-VEGF injections are commonly used for macular oedema. Intravitreal corticosteroids may be considered in selected cases. Laser treatment is used for specific complications, including retinal or anterior-segment neovascularisation, according to the clinical findings. Systemic risk factors should be assessed and managed. Patients require follow-up for persistent macular oedema, retinal ischaemia and neovascular glaucoma.

5. Central Serous Chorioretinopathy (CSCR)

Central serous chorioretinopathy is characterised by serous fluid accumulation beneath the neurosensory retina, usually involving the macula. It commonly affects adults and may be associated with stress, corticosteroid exposure, sleep disturbances and certain systemic conditions.

Symptoms: Blurred central vision, micropsia (objects appearing smaller), distortion of straight lines and reduced contrast.

Diagnosis: OCT demonstrates subretinal fluid and may reveal pigment epithelial detachments. Fundus examination and fluorescein angiography can help confirm the diagnosis and distinguish it from other causes of subretinal fluid.

Management: Many acute cases resolve spontaneously over several weeks to months. Corticosteroid exposure should be reviewed with the prescribing clinician, and unnecessary steroid use avoided. Persistent or recurrent disease may require photodynamic therapy or selected laser treatments. Anti-VEGF therapy is not routine for uncomplicated CSCR but may be indicated when associated macular neovascularisation is present.

6. Epiretinal Membrane and Macular Hole

An epiretinal membrane is a thin fibrocellular layer that develops on the retinal surface, usually over the macula. Contraction of the membrane may distort the retinal architecture and impair central vision. Patients may experience blurred vision, distortion or difficulty reading.

A macular hole is a full-thickness defect in the central retina, commonly associated with vitreomacular traction and age-related vitreous changes. Symptoms include central blurring, distortion and a central blind spot.

Diagnosis: Dilated fundus examination and OCT are the principal investigations. OCT helps assess membrane thickness, traction, retinal distortion and the size and configuration of a macular hole.

Management: Mild epiretinal membranes with limited symptoms can be monitored. Pars plana vitrectomy with membrane peeling may be considered when visual impairment or distortion significantly affects daily activities. Macular holes often require vitrectomy, internal limiting membrane peeling and intraocular gas tamponade. The outcome depends on the size and duration of the hole and the condition of the surrounding retina.

7. Retinitis Pigmentosa and Inherited Retinal Diseases

Retinitis pigmentosa (RP) is a group of inherited retinal dystrophies characterised by progressive degeneration of photoreceptors, particularly rods initially and cones in later stages. Patients typically develop night blindness, followed by progressive peripheral visual field loss and, in advanced disease, reduced central vision.

Diagnosis: Fundus examination may reveal bone-spicule pigmentation, arteriolar attenuation and optic disc pallor. Visual field testing, electroretinography, OCT and genetic testing help establish the diagnosis and assess disease severity.

Management: There is currently no universal cure for RP. Management includes genetic counselling, low-vision rehabilitation, assessment for treatable complications such as cataract and cystoid macular oedema, and referral for specialist evaluation of gene-specific treatments or clinical trials where appropriate. Other inherited retinal diseases, including Stargardt disease and cone-rod dystrophy, require disease-specific assessment and counselling.

8. Retinopathy of Prematurity (ROP)

Retinopathy of prematurity is a disorder of retinal vascular development in premature infants. It occurs because retinal blood vessels have not completed their normal development at birth. Risk is particularly associated with lower gestational age and birth weight, although other neonatal factors also influence the risk.

ROP can regress spontaneously, but severe disease may progress to retinal detachment and permanent visual impairment.

Diagnosis: Scheduled retinal examinations by trained ophthalmologists according to established neonatal screening criteria and local protocols are essential. Screening should not be delayed because the infant appears visually normal.

Management: Selected cases require close observation, while treatment-requiring ROP may be managed with laser photocoagulation or intravitreal anti-VEGF therapy. Advanced retinal detachment may require vitreoretinal surgery. Long-term follow-up is necessary because premature infants remain at increased risk of refractive errors, strabismus, amblyopia and other visual complications.

9. Other Important Retinal Disorders

Hypertensive retinopathy: Sustained or severe hypertension can damage retinal arterioles, producing narrowing, arteriovenous crossing changes, haemorrhages, cotton-wool spots and, in severe cases, optic disc swelling. Management centres on appropriate blood pressure control and assessment for systemic end-organ damage. Severe hypertension with retinal haemorrhages, disc swelling or visual symptoms requires urgent medical evaluation.

Retinal artery occlusion: Sudden painless visual loss may result from central or branch retinal artery occlusion. This is an ocular and systemic vascular emergency because of its association with stroke and other cardiovascular events. Immediate emergency assessment and stroke evaluation are required.

Vitreous haemorrhage: Bleeding into the vitreous may cause floaters, cobweb-like shadows or sudden visual loss. Common causes include proliferative diabetic retinopathy, retinal tears and trauma. Diagnosis requires examination of the retina; B-scan ultrasonography may be necessary when the fundus view is obscured. Treatment depends on the underlying cause and may involve laser or vitrectomy.

Macular oedema: Fluid accumulation within the macula may occur in diabetes, retinal vein occlusion, inflammation and after ocular surgery. OCT is central to diagnosis and monitoring. Treatment depends on the cause and may include anti-VEGF injections, corticosteroids or management of the underlying condition.

or emergency ophthalmic evaluation, depending on their presentation.

Conclusion

 patient education and timely referral are essential to prevent avoidable blindness.